MOSS — Moss Genomics Balance Sheet
0.000.00%
- CA$0.90m
- CA$0.87m
Annual balance sheet for Moss Genomics, fiscal year end - June 30th, CAD millions except per share, conversion factor applied.
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | PROSPECTUS | PROSPECTUS | PROSPECTUS | PROSPECTUS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0.001 | 0.001 | 0.001 | 0.688 | 0.018 |
Net Total Receivables | 0.008 | 0.008 | 0.108 | 0.002 | 0.016 |
Prepaid Expenses | |||||
Total Current Assets | 0.009 | 0.009 | 0.109 | 0.689 | 0.06 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | — | — | — | 0.112 | 0.067 |
Total Assets | 0.009 | 0.009 | 0.109 | 0.802 | 0.127 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Current Liabilities | 0.011 | 0.012 | 0.12 | 0.14 | 0.051 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Liabilities | 0.011 | 0.012 | 0.12 | 0.14 | 0.051 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | -0.002 | -0.003 | -0.012 | 0.661 | 0.076 |
Total Liabilities & Shareholders' Equity | 0.009 | 0.009 | 0.109 | 0.802 | 0.127 |
Total Common Shares Outstanding |